CURRENT PHARMACEUTICAL BIOTECHNOLOGY, cilt.20, sa.4, ss.317-326, 2019 (SCI-Expanded)
Background: The global rise of multi-drug resistant M. tuberculosis demands unconventional treatment to enhance the efficiency of current drugs. Punica granatum, which is known as pomegranate, is considered as a member of the Punicaceae family. Pomegranate, which is broadly documented for its activity against a wide spectrum of bacterial pathogens, deserves further scrutiny in this respect.